ArticleCancer research2011

Combined treatment of pancreatic cancer with mithramycin a and tolfenamic Acid promotes sp1 degradation and synergistic antitumor activity--letter.

Ting-Chao ChouPubMed ↗Publisher ↗

No numbers read from the abstract.